Carcinogenesis, Teratogenesis & Mutagenesis ›› 2016, Vol. 28 ›› Issue (2): 145-148.doi: 10.3969/j.issn.1004-616x.2016.02.013

Previous Articles     Next Articles

Analysis on screening and prenatal diagnosis of non-deletion α-thalassemia in Guangzhou

QU Yanxia1, CHEN Guilan1, TANG Ying1, JIANG Fan1, ZUO Liandong1, GU Junmei2, LI Zhihua3   

  1. 1. Guangzhou women and Children's Medical Center, Guangzhou 510623;
    2. Family Planning Service Station of Panyu District, Guangzhou 518000;
    3. The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, Guangdong, China
  • Received:2015-08-17 Revised:2015-10-26 Online:2016-03-31 Published:2016-03-31

Abstract: OBJECTIVE: To explore the gene mutation types and proportions of non-deletion α-thalassemia, and to provide clinical basis for genetic counselling. METHODS: The gene mutation types and frequencies of 259 suspected non-deletion α-thalassemia patients were analyzed by Gap-PCR and PCR-RDB. 30 pregnant women whose husband had the same type of thalassemia received thalassemia prenatal diagnosis. We completed follow-up works. RESULTS: Among the 259 cases, 170 cases of ααQS/αα, 43 cases of ααWS/αα, 34 cases of ααCS/αα, 6 cases of——SEA/ααQS, 4 cases of——SEA/ααCS, one case of -α3.7/ααQS, and one case of -α4.2/ααQS were found. Compared with normal control group, there were statistical significances in MCV, MCH in different types of non-deletion α-thalassemia (P<0.05). 5 fetuses with non-deletion HbH disease were confirmed by prenatal diagnosis. The results of postpartum follow-up were consistent with prenatal diagnoses. CONCLUSION: Guangzhou is a high incidence area of non-deletion α-thalassemia. The most common genotype is ααQS/αα. To reduce the birth of children with non-deletion HbH disease, non-deletion thalassemia genotype carriers should be tested.

Key words: non-deletion α-thalassemia, mutation, gene diagnosis, prenatal diagnosis

CLC Number: